Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
34422142
PubMed Central
PMC8368050
DOI
10.1007/s13167-021-00251-4
PII: 251
Knihovny.cz E-zdroje
- Klíčová slova
- Adults, Anorexia athletica, Anthropometrics, Artificial intelligence in medicine, BMI deviation, Big data management, Biomarker panel, Body fluids, Body weight, COVID-19, Cancers, Cardiovascular disease, Communicable, Deficits, Disease development, Elderly, Endothelin-1, Fat, Flammer syndrome, Health economy, Health policy, Healthcare, Hypoxic effects, Immune system, Individualised patient profile, Inflammation, Innovative population Screening Programme, Intentional, Manifestation, Medical imaging, Metabolic pathways, Microbiome, Modelling, Molecular patterns, Multi-level diagnostics, Multi-parametric analysis, Neurodegeneration, Neurology, Non-communicable disorders, Nutrition, Overweight, Pathology, Population health, Predictive preventive personalised medicine (3PM/PPPM), Pregnancy, Progression, ROS, Reproductive dysfunction, Sports medicine, Stroke, Systemic ischemia, Underweight, Unintentional, Vasoconstriction, Weight loss, Well-being, Wound healing, Youth,
- Publikační typ
- časopisecké články MeSH
An increasing interest in a healthy lifestyle raises questions about optimal body weight. Evidently, it should be clearly discriminated between the standardised "normal" body weight and individually optimal weight. To this end, the basic principle of personalised medicine "one size does not fit all" has to be applied. Contextually, "normal" but e.g. borderline body mass index might be optimal for one person but apparently suboptimal for another one strongly depending on the individual genetic predisposition, geographic origin, cultural and nutritional habits and relevant lifestyle parameters-all included into comprehensive individual patient profile. Even if only slightly deviant, both overweight and underweight are acknowledged risk factors for a shifted metabolism which, if being not optimised, may strongly contribute to the development and progression of severe pathologies. Development of innovative screening programmes is essential to promote population health by application of health risks assessment, individualised patient profiling and multi-parametric analysis, further used for cost-effective targeted prevention and treatments tailored to the person. The following healthcare areas are considered to be potentially strongly benefiting from the above proposed measures: suboptimal health conditions, sports medicine, stress overload and associated complications, planned pregnancies, periodontal health and dentistry, sleep medicine, eye health and disorders, inflammatory disorders, healing and pain management, metabolic disorders, cardiovascular disease, cancers, psychiatric and neurologic disorders, stroke of known and unknown aetiology, improved individual and population outcomes under pandemic conditions such as COVID-19. In a long-term way, a significantly improved healthcare economy is one of benefits of the proposed paradigm shift from reactive to Predictive, Preventive and Personalised Medicine (PPPM/3PM). A tight collaboration between all stakeholders including scientific community, healthcare givers, patient organisations, policy-makers and educators is essential for the smooth implementation of 3PM concepts in daily practice.
AMEOS Clinical Centre for Psychiatry and Psychotherapy 31135 Hildesheim Germany
Biomedical Centre Faculty of Medicine in Pilsen Charles University Staré Město Czech Republic
European Depression Association Brussels Belgium
Nutrition Department Ashkelon Academic College Ashkelon Tel Aviv Israel
Private Institute of Applied Ophthalmology Berlin Germany
Stavropol State Medical University Stavropol Russian Federation
UCB Biosciences GmbH Alfred Nobel Str 10 40789 Monheim am Rhein Germany
Ultrasound Department Clinical Hospital Pheophania Kyiv Ukraine
Weill Cornell Medicine Qatar Education City Qatar Foundation 24144 Doha Qatar
Zobrazit více v PubMed
Wijnhoven TM, van Raaij JM, Spinelli A, Starc G, Hassapidou M, Spiroski I, Rutter H, Martos É, Rito AI, Hovengen R, et al. WHO European Childhood Obesity Surveillance Initiative: body mass index and level of overweight among 6–9-year-old children from school year 2007/2008 to school year 2009/2010. BMC Public Health. 2014;14:806. doi: 10.1186/1471-2458-14-806. PubMed DOI PMC
Lazzeri G, Rossi S, Kelly C, Vereecken C, Ahluwalia N, Giacchi MV. Trends in thinness prevalence among adolescents in ten European countries and the USA (1998–2006): a cross-sectional survey. Public Health Nutr. 2014;17:2207–2215. doi: 10.1017/S1368980013002541. PubMed DOI PMC
Garrido-Miguel M, Cavero-Redondo I, Álvarez-Bueno C, Rodriguez-Artalejo F, Aznar LM, Ruiz JR, Martinez-Vizcaino V. Prevalence and trends of thinness, overweight and obesity among children and adolescents aged 3–18 years across Europe: a protocol for a systematic review and meta-analysis. BMJ Open. 2017;7:e018241. doi: 10.1136/bmjopen-2017-018241. PubMed DOI PMC
Flammer syndrome: from phenotype to associated pathologies, Prediction, Prevention and Personalisation. Golubnitschaja O, (ed.), Advances in Predictive, Preventive and Personalised Medicine. Springer International Publishing. 2019; ISBN 978–3–030–13549–2.
Bhaskaran K, dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944–953. doi: 10.1016/S2213-8587(18)30288-2. PubMed DOI PMC
Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, Golubnitschaja O. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11:399–418. doi: 10.1007/s13167-020-00214-1. PubMed DOI PMC
Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T, et al. Flammer syndrome. EPMA J. 2014;5:11. doi: 10.1186/1878-5085-5-11. PubMed DOI PMC
Golubnitschaja O, Flammer J. Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for Predictive Preventive and Personalised Medicine. EPMA J. 2018;9:15–20. doi: 10.1007/s13167-018-0127-9. PubMed DOI PMC
Golubnitschaja O. Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J. 2017;8:17–22. doi: 10.1007/s13167-017-0086-6. PubMed DOI PMC
Fröhlich H, Patjoshi S, Yeghiazaryan K, Kehrer C, Kuhn W, Golubnitschaja O. Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification. EPMA J. 2018;9:175–186. doi: 10.1007/s13167-018-0131-0. PubMed DOI PMC
Kunin A, Polivka J, Moiseeva N, Golubnitschaja O. “Dry mouth” and “Flammer” syndromes-neglected risks in adolescents and new concepts by Predictive Preventive and Personalised Approach. EPMA J. 2018;9:307–317. doi: 10.1007/s13167-018-0145-7. PubMed DOI PMC
Polivka J, Polivka J, Pesta M, Rohan V, Celedova L, Mahajani S, Topolcan O, Golubnitschaja O. Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach. EPMA J. 2019;10:81–99. doi: 10.1007/s13167-019-00162-5. PubMed DOI PMC
Goncharenko V, Bubnov R, Polivka J, Zubor P, Biringer K, Bielik T, Kuhn W, Golubnitschaja O. Vaginal dryness: individualised patient profiles, risks and mitigating measures. EPMA J. 2019;10:73–79. doi: 10.1007/s13167-019-00164-3. PubMed DOI PMC
Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, Varghese E, Abotaleb M, Qaradakhi T, Zulli A, et al. Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J. 2020;11:377–398. doi: 10.1007/s13167-020-00217-y. PubMed DOI PMC
Kunin A, Sargheini N, Birkenbihl C, Moiseeva N, Fröhlich H, Golubnitschaja O. Voice perturbations under the stress overload in young individuals: phenotyping and suboptimal health as predictors for cascading pathologies. EPMA J. 2020;11:517–527. doi: 10.1007/s13167-020-00229-8. PubMed DOI PMC
Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, Golubnitschaja O. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? EPMA J. 2020;1–25. 10.1007/s13167-020-00226-x. PubMed PMC
Crigna AT, Link B, Samec M, Giordano FA, Kubatka P, Golubnitschaja O. Endothelin-1 axes in the framework of Predictive, Preventive and Personalised (3P) Medicine. EPMA J. 2021. 10.1007/s13167-021-00248-z. PubMed PMC
Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617–625. doi: 10.1016/S1470-2045(04)01597-9. PubMed DOI
Richter K, Kellner S, Hillemacher T, Golubnitschaja O. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of Predictive, Preventive and Personalised (3P) Medicine. EPMA J. 2021;1–21. 10.1007/s13167-021-00245-2. PubMed PMC
Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O. Mitochondriopathies as a clue to systemic disorders—analytical tools and mitigating measures in context of Predictive, Preventive, and Personalized (3P) Medicine. Int J Mol Sci. 2021;22. 10.3390/ijms22042007. PubMed PMC
Koklesova L, Samec M, Liskova A, Zhai K, Büsselberg D, Giordano FA, Kubatka P, Golunitschaja O. Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine. EPMA J. 2021;1–14. 10.1007/s13167-021-00237-2. PubMed PMC
Liskova A, Koklesova L, Samec M, Abdellatif B, Zhai K, Siddiqui M, Šudomová M, Hassan STS, Kudela E, Biringer K, et al. Targeting phyto-protection to COVID-19 induced lung damage and associated systemic effects – the evidence-based 3PM proposition to mitigate individual risks. EPMA J. 2021. in print. PubMed PMC
Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 2019;10:365–381. doi: 10.1007/s13167-019-00194-x. PubMed DOI PMC
Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in Predictive Preventive and Personalised Medicine. EPMA J. 2017;8:23–33. doi: 10.1007/s13167-017-0081-y. PubMed DOI PMC
The modern hospital: patients centered, disease based, research oriented, technology driven; 1st edition. New York: Springer Berlin Heidelberg. 2018; ISBN 978–3–030–01393–6.
Deyell M, Garris CS, Laughney AM. Cancer metastasis as a non-healing wound. Br J Cancer. 2021;124:1491–1502. doi: 10.1038/s41416-021-01309-w. PubMed DOI PMC
Bosch X, Monclús E, Escoda O, Guerra-García M, Moreno P, Guasch N, López-Soto A. Unintentional weight loss: clinical characteristics and outcomes in a prospective cohort of 2677 patients. PLoS ONE. 2017;12:e0175125. doi: 10.1371/journal.pone.0175125. PubMed DOI PMC
Gaddey HL, Holder K. Unintentional weight loss in older adults. Am Fam Physician. 2014;89:718–722. PubMed
Miller SL, Wolfe RR. The danger of weight loss in the elderly. J Nutr Health Aging. 2008;12:487–491. doi: 10.1007/BF02982710. PubMed DOI
Shen L-J, Chen C, Li B-F, Gao J, Xia Y-F. High Weight loss during radiation treatment changes the prognosis in under-/normal weight nasopharyngeal carcinoma patients for the worse: a retrospective analysis of 2433 cases. PLoS ONE. 2013;8:e68660. doi: 10.1371/journal.pone.0068660. PubMed DOI PMC
Soeters P, Bozzetti F, Cynober L, Forbes A, Shenkin A, Sobotka L. Defining malnutrition: a plea to rethink. Clin Nutr. 2017;36:896–901. doi: 10.1016/j.clnu.2016.09.032. PubMed DOI
Loh KW, Vriens MR, Gerritsen A, BorelRinkes IHM, van Hillegersberg R, Schippers C, Steenhagen E, Ong TA, Moy FM, Molenaar IQ. Unintentional weight loss is the most important indicator of malnutrition among surgical cancer patients. Neth J Med. 2012;70:365–369. PubMed
Atlantis E, Browning C, Kendig H. Body mass index and unintentional weight change associated with all-cause mortality in older australians: the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA) Age Ageing. 2010;39:559–565. doi: 10.1093/ageing/afq073. PubMed DOI
Jou J, Coulter E, Roberts T, Binder P, Saenz C, McHale M, Plaxe S, Mayadev J, Eskander RN. Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation. Gynecol Oncol. 2021;160:721–728. doi: 10.1016/j.ygyno.2020.12.009. PubMed DOI
Yoon SL, Kim JA, Kelly DL, Lyon D, George TJ. Predicting unintentional weight loss in patients with gastrointestinal cancer. J Cachexia Sarcopenia Muscle. 2019;10:526–535. doi: 10.1002/jcsm.12398. PubMed DOI PMC
Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev. 2002;3:141–146. doi: 10.1046/j.1467-789X.2002.00065.x. PubMed DOI
Bhogal MS, Langford R. Gender differences in weight loss: evidence from a NHS weight management service. Public Health. 2014;128:811–813. doi: 10.1016/j.puhe.2014.06.019. PubMed DOI
Christensen P, Meinert Larsen T, Westerterp-Plantenga M, Macdonald I, Martinez JA, Handjiev S, Poppitt S, Hansen S, Ritz C, Astrup A, et al. Men and women respond differently to rapid weight loss: metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW) Diabetes Obes Metab. 2018;20:2840–2851. doi: 10.1111/dom.13466. PubMed DOI PMC
Lorenzini A. How much should we weigh for a long and healthy life span? The need to reconcile caloric restriction versus longevity with body mass index versus mortality data. Front Endocrinol (Lausanne). 2014;5. 10.3389/fendo.2014.00121. PubMed PMC
Prescott HC, Chang VW. Overweight or obese BMI is associated with earlier, but not later survival after common acute illnesses. BMC Geriatr. 2018;18. 10.1186/s12877-018-0726-2. PubMed PMC
Lorem GF, Schirmer H, Emaus N. What is the impact of underweight on self-reported health trajectories and mortality rates: a cohort study. Health Qual Life Outcomes. 2017;15. 10.1186/s12955-017-0766-x. PubMed PMC
Park D, Lee J-H, Han S. Underweight: another risk factor for cardiovascular disease? Medicine (Baltimore). 2017;96. 10.1097/MD.0000000000008769. PubMed PMC
Funada S, Shimazu T, Kakizaki M, Kuriyama S, Sato Y, Matsuda-Ohmori K, Nishino Y, Tsuji I. Body mass index and cardiovascular disease mortality in Japan: the Ohsaki Study. Prev Med. 2008;47:66–70. doi: 10.1016/j.ypmed.2008.03.010. PubMed DOI
Chen H-N, Chen X-Z, Zhang W-H, Yang K, Chen X-L, Zhang B, Chen Z-X, Chen J-P, Zhou Z-G, Hu J-K. The impact of body mass index on the surgical outcomes of patients with gastric cancer. Medicine (Baltimore). 2015;94. 10.1097/MD.0000000000001769. PubMed PMC
Chen B, Lai J, Guo L, Dai D, Chen R, Wei G, Liao N. Adverse effects of being underweight on young female breast cancer patients with lymph node metastases. J Cancer. 2020;11:1976–1984. doi: 10.7150/jca.38567. PubMed DOI PMC
Kim JH, Yoon KH, Hur H, Park S, Kim JY, Park HS, Kim SI, Cho YU, Park B-W. Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV-VI. Breast Cancer Res Treat. 2019;174:515–524. doi: 10.1007/s10549-018-05091-x. PubMed DOI
Bubnov R, Polivka J, Zubor P, Konieczka K, Golubnitschaja O. “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer syndrome” relevance to address the question. EPMA J. 2017;8:141–157. doi: 10.1007/s13167-017-0092-8. PubMed DOI PMC
Stolzenburg-Veeser L, Golubnitschaja O. Mini-encyclopaedia of the wound healing - opportunities for integrating multi-omic approaches into medical practice. J Proteomics. 2018;188:71–84. doi: 10.1016/j.jprot.2017.07.017. PubMed DOI
Manrique J, Chen AF, Gomez MM, Maltenfort MG, Hozack WJ. Surgical site infection and transfusion rates are higher in underweight total knee arthroplasty patients. Arthroplasty Today. 2016;3:57–60. doi: 10.1016/j.artd.2016.03.005. PubMed DOI PMC
Zorrilla P, Gómez LA, Salido JA, Silva A, López-Alonso A. Low serum zinc level as a predictive factor of delayed wound healing in total hip replacement. Wound Repair Regen. 2006;14:119–122. doi: 10.1111/j.1743-6109.2006.00100.x. PubMed DOI
Boutari C, Pappas PD, Mintziori G, Nigdelis MP, Athanasiadis L, Goulis DG, Mantzoros CS. The effect of underweight on female and male reproduction. Metabolism. 2020;107:154229. doi: 10.1016/j.metabol.2020.154229. PubMed DOI
Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2010;2010. 10.1155/2010/625105. PubMed PMC
Oliveira JBA. Does low BMI affect ART outcomes? JBRA Assist Reprod. 2018;22:1. doi: 10.5935/1518-0557.20180021. PubMed DOI PMC
Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome? J Assist Reprod Genet. 2000;17:547–552. doi: 10.1023/a:1026477628723. PubMed DOI PMC
Veleva Z, Tiitinen A, Vilska S, Hydén-Granskog C, Tomás C, Martikainen H, Tapanainen JS. High and low BMI increase the risk of miscarriage after IVF/ICSI and FET. Hum Reprod. 2008;23:878–884. doi: 10.1093/humrep/den017. PubMed DOI
Ruffner MA, Sullivan KE. Complications associated with underweight primary immunodeficiency patients: prevalence and associations within the USIDNET registry. J Clin Immunol. 2018;38:283–293. doi: 10.1007/s10875-018-0492-0. PubMed DOI PMC
Mertens E, Peñalvo JL. The burden of malnutrition and fatal COVID-19: a global burden of disease analysis. Front Nutr. 2021;7. 10.3389/fnut.2020.619850. PubMed PMC
Bramley AM, Reed C, Finelli L, Self WH, Ampofo K, Arnold SR, Williams DJ, Grijalva CG, Anderson EJ, Stockmann C, et al. Relationship between body mass index and outcomes among hospitalized patients with community-acquired pneumonia. J Infect Dis. 2017;215:1873–1882. doi: 10.1093/infdis/jix241. PubMed DOI PMC
Wyrick S, Hester C, Sparkman A, O’Neill KM, Dupuis G, Anderson M, Cordell J, Bogie A. What role does body mass index play in hospital admission rates from the pediatric emergency department? Pediatr Emerg Care. 2013;29:974–978. doi: 10.1097/PEC.0b013e3182a21a23. PubMed DOI
O’Brien KM, Whelan DR, Sandler DP, Hall JE, Weinberg CR. Predictors and long-term health outcomes of eating disorders. PLoS One 2017;12. 10.1371/journal.pone.0181104. PubMed PMC
Geoffroy M-C, Li L, Power C. Depressive symptoms and body mass index: co-morbidity and direction of association in a British birth cohort followed over 50 years. Psychol Med. 2014;44:2641–2652. doi: 10.1017/S0033291714000142. PubMed DOI
Konieczka K, Koch S, Schoetzau A, Todorova MG. Increased prevalence of Flammer syndrome in patients with retinitis pigmentosa. Klin Monbl Augenheilkd. 2016;233:448–452. doi: 10.1055/s-0041-111802. PubMed DOI
Azarbal F, Stefanick ML, Assimes TL, Manson JE, Bea JW, Li W, Hlatky MA, Larson JC, LeBlanc ES, Albert CM, et al. Lean body mass and risk of incident atrial fibrillation in post-menopausal women. Eur Heart J. 2016;37:1606–1613. doi: 10.1093/eurheartj/ehv423. PubMed DOI PMC
Bucholz EM, Krumholz HA, Krumholz HM. Underweight, markers of cachexia, and mortality in acute myocardial infarction: a prospective cohort study of elderly Medicare beneficiaries. PLoS Med. 2016;13:e1001998. doi: 10.1371/journal.pmed.1001998. PubMed DOI PMC
Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, Arbab-Zadeh A, Mukherjee D, Lazar JM. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115:1428–1434. doi: 10.1016/j.amjcard.2015.02.024. PubMed DOI
Lavie CJ, De Schutter A, Parto P, Jahangir E, Kokkinos P, Ortega FB, Arena R, Milani RV. Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated. Prog Cardiovasc Dis. 2016;58:537–547. doi: 10.1016/j.pcad.2016.01.008. PubMed DOI
Nagarajan V, Kohan L, Holland E, Keeley EC, Mazimba S. Obesity paradox in heart failure: a heavy Matter. ESC Heart Fail. 2016;3:227–234. doi: 10.1002/ehf2.12120. PubMed DOI PMC
Donataccio MP, Vanzo A, Bosello O. Obesity paradox and heart failure. Eat Weight Disord. 2020. 10.1007/s40519-020-00982-9. PubMed
Carbonell-Bobadilla N, Rodríguez-Álvarez AA, Rojas-García G, Barragán-Garfias JA, Orrantia-Vertiz M, Rodríguez-Romo R. Joint hypermobility syndrome. Acta Ortop Mex. 2020;34:441–449. doi: 10.35366/99145. PubMed DOI
Fenger-Grøn M, Overvad K, Tjønneland A, Frost L. Lean body mass is the predominant anthropometric risk factor for atrial fibrillation. J Am Coll Cardiol. 2017;69:2488–2497. doi: 10.1016/j.jacc.2017.03.558. PubMed DOI
Gerner C, Costigliola V, Golubnitschaja O. Multiomic patterns in body fluids: technological challenge with a great potential to implement the advanced paradigm of 3P medicine. Mass Spectrom Rev. 2020;39:442–451. doi: 10.1002/mas.21612. PubMed DOI
Bubnov R, Kalika L. Ab0910 Effective restoring motion and effective treatment of myofascial and neuropathic low back pain by targeted dry needling using ultrasound guidance. Ann Rheum Dis. 2019;78:1921–1922. doi: 10.1136/annrheumdis-2019-eular.5533. DOI
Bubnov R, Golubnitschaja O. Ab0961 Myofascial trigger points are the underevaluated hypoxic nisches altering posture and phenotype. Ann Rheum Dis. 2020;79:1777–1777. doi: 10.1136/annrheumdis-2020-eular.1962. DOI
Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, Gottrup F, Gurtner GC, Longaker MT. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763–771. doi: 10.1111/j.1524-475X.2009.00543.x. PubMed DOI PMC
Flegal KM, Kit BK, Graubard BI. Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol. 2014;180:288–296. doi: 10.1093/aje/kwu111. PubMed DOI PMC
Vajapey S, Matic G, Hartz C, Miller TL. Sacral stress fractures: a rare but curable cause of back pain in athletes. Sports Health. 2019;11:446–452. doi: 10.1177/1941738119854763. PubMed DOI PMC
Jamieson M, Schroeder A, Campbell J, Seigel C, Everson S, Miller TL. Time to return to running after tibial stress fracture in female division I collegiate track and field. Current Orthopaedic Practice. 2017;28:393–397. doi: 10.1097/BCO.0000000000000524. DOI
Zusmanovich M, Kester B, Feng J, Schwarzkopf R. Postoperative complications in underweight patients undergoing total hip arthroplasty: a comparative analysis to normal weight patients. J Orthop. 2018;15:345–348. doi: 10.1016/j.jor.2018.02.016. PubMed DOI PMC
Hingorani P, Seidel K, Krailo M, Mascarenhas L, Meyers P, Marina N, Conrad EU, Hawkins DS. Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the children’s oncology group. Pediatr Blood Cancer. 2011;57:939–942. doi: 10.1002/pbc.23129. PubMed DOI PMC
Kang J, Lee SH, Son JH, Lee JW, Choi YH, Choi JH, Paik WH, Ryu JK, Kim Y-T. Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients. PLoS ONE. 2013;13:e0195118. doi: 10.1371/journal.pone.0195118. PubMed DOI PMC
Shepshelovich D, Xu W, Lu L, Fares A, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, et al. Body mass index (BMI), BMI change, and overall survival in patients with SCLC and NSCLC: a pooled analysis of the international lung cancer consortium. J Thorac Oncol. 2019;14:1594–1607. doi: 10.1016/j.jtho.2019.05.031. PubMed DOI PMC
Matsunaga T, Suzuki K, Imashimizu K, Banno T, Takamochi K, Oh S. Body mass index as a prognostic factor in resected lung cancer: obesity or underweight, which is the risk factor? Thorac Cardiovasc Surg. 2015;63:551–557. doi: 10.1055/s-0035-1554964. PubMed DOI
Kaneko M, Sasaki S, Ozaki K, Ishimaru K, Terai E, Nakayama H, Watanabe T. Underweight status predicts a poor prognosis in elderly patients with colorectal cancer. Mol Clin Oncol. 2016;5:289–294. doi: 10.3892/mco.2016.964. PubMed DOI PMC
Greenlee H, Unger JM, LeBlanc M, Ramsey S, Hershman DL. Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials. Cancer Epidemiol Biomarkers Prev. 2017;26:21–29. doi: 10.1158/1055-9965.EPI-15-1336. PubMed DOI PMC
Zhao J, Stockwell T, Roemer A, Chikritzhs T. Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis. BMC Cancer. 2016;16:845. doi: 10.1186/s12885-016-2891-z. PubMed DOI PMC
Zubor P, Gondova A, Polivka J, Kasajova P, Konieczka K, Danko J, Golubnitschaja O. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J. 2017;8:129–140. doi: 10.1007/s13167-017-0089-3. PubMed DOI PMC
Charkhchi P, Schabath MB, Carlos RC. Breast, cervical, and colorectal cancer screening adherence: effect of low body mass index in women. J Womens Health (Larchmt) 2020;29:996–1006. doi: 10.1089/jwh.2019.7739. PubMed DOI
https://www.epmanet.eu/young-professionals/awards/2019 Available online: https://www.epmanet.eu/young-professionals/awards/2019 (accessed on 23 Jul 2021).
Golubnitschaja O, Topolcan O, Kucera R, Costigliola V, Akopyan M, Akulov SN, Alexandrova O, Alonso A, Andrews RJ, Duarte AA, et al. 10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020. EPMA J. 2020;11:1–133. doi: 10.1007/s13167-020-00206-1. PubMed DOI PMC
Aladashvili-Chikvaidze N, Kristesashvili J, Gegechkori M. Types of reproductive disorders in underweight and overweight young females and correlations of respective hormonal changes with BMI. Iran J Reprod Med. 2015;13:135–140. PubMed PMC
Tang S, Huang J, Lin J, Kuang Y. Adverse effects of pre-pregnancy maternal underweight on pregnancy and perinatal outcomes in a freeze-all policy. BMC Pregnancy Childbirth. 2021;21:32. doi: 10.1186/s12884-020-03509-3. PubMed DOI PMC
Guo D, Xu M, Zhou Q, Wu C, Ju R, Dai J. Is low body mass index a risk factor for semen quality? A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2019;98. 10.1097/MD.0000000000016677. PubMed PMC
Huang H-K, Bukhari K, Peng CC-H, Hung D-P, Shih M-C, Chang RH-E, Lin S-M, Munir KM, Tu Y-K. The J-shaped relationship between body mass index and mortality in patients with COVID-19: a dose-response meta-analysis. Diabetes Obes Metab. 2021;n/a. 10.1111/dom.14382. PubMed PMC
Moser J-AS, Galindo-Fraga A, Ortiz-Hernández AA, Gu W, Hunsberger S, Galán-Herrera J-F, Guerrero ML, Ruiz-Palacios GM, Beigel JH. La Red ILI 002 Study Group Underweight, Overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respir Viruses. 2019;13:3–9. doi: 10.1111/irv.12618. PubMed DOI PMC
Yu H, Feng Z, Uyeki TM, Liao Q, Zhou L, Feng L, Ye M, Xiang N, Huai Y, Yuan Y, et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis. 2011;52:457–465. doi: 10.1093/cid/ciq144. PubMed DOI PMC
Harpsøe MC, Nielsen NM, Friis-Møller N, Andersson M, Wohlfahrt J, Linneberg A, Nohr EA, Jess T. Body mass index and risk of infections among women in the Danish National Birth Cohort. Am J Epidemiol. 2016;183:1008–1017. doi: 10.1093/aje/kwv300. PubMed DOI
Provencher MT, Chahla J, Sanchez G, Cinque ME, Kennedy NI, Whalen J, Price MD, Moatshe G, LaPrade RF. Body mass index versus body fat percentage in prospective national football league athletes: overestimation of obesity rate in athletes at the national football league scouting combine. J Strength Cond Res. 2018;32:1013–1019. doi: 10.1519/JSC.0000000000002449. PubMed DOI
Stolk RP, Meijer R, Mali WPTM, Grobbee DE, van der Graaf Y. Secondary manifestations of arterial disease study group ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr. 2003;77:857–860. doi: 10.1093/ajcn/77.4.857. PubMed DOI
Hiremath R. Comparative study of ultrasonographic and anthropometric measurements of regional adiposity in metabolic syndrome. JCDR 2017. 10.7860/JCDR/2017/26386.10352. PubMed PMC
Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, Yoshizumi M, Toba K, Ouchi Y. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes. 1998;22:477–484. doi: 10.1038/sj.ijo.0800620. PubMed DOI
Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol. 2009;11:414–430. doi: 10.1007/s11940-009-0046-0. PubMed DOI PMC
Yoshida K, Ohguro I, Ohguro H. Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma. J Ocul Pharmacol Ther. 2013;29:480–487. doi: 10.1089/jop.2012.0198. PubMed DOI PMC
Tachalov V, Orechova L, Kudriavtseva T, Loboda E, Pachkoria M, Berezkina I, Golubnitschaja O. Making a complex dental care tailored to the person: population health in focus of Predictive, Preventive and Personalised (3P) medical approach. 2021. 10.21203/rs.3.rs-362468/v1. PubMed PMC
Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, Creasy HH, Earl AM, FitzGerald MG, Fulton RS, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214. doi: 10.1038/nature11234. PubMed DOI PMC
Parekh PJ, Balart LA, Johnson DA. The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease. Clin Transl Gastroenterol. 2015;6:e91. doi: 10.1038/ctg.2015.16. PubMed DOI PMC
Aron-Wisnewsky J, Clément K. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat Rev Nephrol. 2016;12:169–181. doi: 10.1038/nrneph.2015.191. PubMed DOI
Bubnov RV, Spivak MY, Lazarenko LM, Bomba A, Boyko NV. Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA Journal. 2015;6:14. doi: 10.1186/s13167-015-0036-0. PubMed DOI PMC
Reid G, Abrahamsson T, Bailey M, Bindels LB, Bubnov R, Ganguli K, Martoni C, O’Neill C, Savignac HM, Stanton C, et al. How do probiotics and prebiotics function at distant sites? Beneficial Microbes. 2017;8:521–533. doi: 10.3920/BM2016.0222. PubMed DOI
Calvani R, Picca A, Lo Monaco MR, Landi F, Bernabei R, Marzetti E. Of microbes and minds: a narrative review on the second brain aging. Front Med. 2018;0. 10.3389/fmed.2018.00053. PubMed PMC
Goodrich JK, Davenport ER, Waters JL, Clark AG, Ley RE. Cross-species comparisons of host genetic associations with the microbiome. Science. 2016;352:532–535. doi: 10.1126/science.aad9379. PubMed DOI PMC
Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15:73. doi: 10.1186/s12967-017-1175-y. PubMed DOI PMC
Kang SS, Jeraldo PR, Kurti A, Miller MEB, Cook MD, Whitlock K, Goldenfeld N, Woods JA, White BA, Chia N, et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener. 2014;9:36. doi: 10.1186/1750-1326-9-36. PubMed DOI PMC
Wilson ID, Nicholson JK. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res. 2017;179:204–222. doi: 10.1016/j.trsl.2016.08.002. PubMed DOI PMC
Clarke SF, Murphy EF, O’Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O’Reilly M, Jeffery IB, Wood-Martin R, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63:1913–1920. doi: 10.1136/gutjnl-2013-306541. PubMed DOI
Clark A, Mach N. The crosstalk between the gut microbiota and mitochondria during exercise. Front Physiol. 2017;0. 10.3389/fphys.2017.00319. PubMed PMC
Thaiss CA, Levy M, Korem T, Dohnalová L, Shapiro H, Jaitin DA, David E, Winter DR, Gury-BenAri M, Tatirovsky E, et al. Microbiota diurnal rhythmicity programs host transcriptome oscillations. Cell. 2016;167:1495–1510.e12. doi: 10.1016/j.cell.2016.11.003. PubMed DOI
Bubnov RV, Babenko LP, Lazarenko LM, Mokrozub VV, Spivak MYA. Specific properties of probiotic strains: relevance and benefits for the host. EPMA J. 2018;9:205–223. doi: 10.1007/s13167-018-0132-z. PubMed DOI PMC
Herpertz-Dahlmann B, Seitz J, Baines J. Food matters: how the microbiome and gut–brain interaction might impact the development and course of anorexia nervosa. Eur Child Adolesc Psychiatry. 2017;26:1031–1041. doi: 10.1007/s00787-017-0945-7. PubMed DOI PMC
Jésus P, Ouelaa W, François M, Riachy L, Guérin C, Aziz M, Rego J-CD, Déchelotte P, Fetissov SO, Coëffier M. Alteration of intestinal barrier function during activity-based anorexia in mice. Clin Nutr. 2014;33:1046–1053. doi: 10.1016/j.clnu.2013.11.006. PubMed DOI
Elia M, Behrens R, Northrop C, Wraight P, Neale G. Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man. Clin Sci. 1987;73:197–204. doi: 10.1042/cs0730197. PubMed DOI
Solmi M, Veronese N, Favaro A, Santonastaso P, Manzato E, Sergi G, Correll CU. Inflammatory cytokines and anorexia nervosa: a meta-analysis of cross-sectional and longitudinal studies. Psychoneuroendocrinology. 2015;51:237–252. doi: 10.1016/j.psyneuen.2014.09.031. PubMed DOI
Corcos M, Guilbaud O, Paterniti S, Moussa M, Chambry J, Chaouat G, Consoli SM, Jeammet P. Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology. 2003;28:229–249. doi: 10.1016/S0306-4530(02)00021-5. PubMed DOI
Smokovski I, Risteski M, Polivka J, Zubor P, Konieczka K, Costigliola V, Golubnitschaja O. Postmenopausal breast cancer: European challenge and innovative concepts. EPMA J. 2017;8:159–169. doi: 10.1007/s13167-017-0094-6. PubMed DOI PMC
Özturan A, Şanlıer N, Coşkun Ö. The relationship between migraine and nutrition. tnd. 2016;22:44–50. doi: 10.4274/tnd.37132. DOI
Nattagh-Eshtivani E, Sani MA, Dahri M, Ghalichi F, Ghavami A, Arjang P, Tarighat-Esfanjani A. The role of nutrients in the pathogenesis and treatment of migraine headaches: review. Biomed Pharmacother. 2018;102:317–325. doi: 10.1016/j.biopha.2018.03.059. PubMed DOI
von Luckner A, Riederer F. Magnesium in migraine prophylaxis-is there an evidence-based rationale? A systematic review. Headache. 2018;58:199–209. doi: 10.1111/head.13217. PubMed DOI
Halson SL. Sleep in elite athletes and nutritional interventions to enhance sleep. Sports Med. 2014;44(Suppl 1):S13–23. doi: 10.1007/s40279-014-0147-0. PubMed DOI PMC
Lauer CJ, Krieg J-C. Sleep in eating disorders. Sleep Med Rev. 2004;8:109–118. doi: 10.1016/S1087-0792(02)00122-3. PubMed DOI
Ghoch ME, Calugi S, Bernabè J, Pellegrini M, Milanese C, Chignola E, Grave RD. Sleep patterns before and after weight restoration in females with anorexia nervosa: a longitudinal controlled study. Eur Eat Disord Rev. 2016;24:425–429. doi: 10.1002/erv.2461. PubMed DOI
Binks H, Vincent EG, Gupta C, Irwin C, Khalesi S. Effects of diet on sleep: a narrative review. Nutrients. 2020;12:936. doi: 10.3390/nu12040936. PubMed DOI PMC
Smolle C, Tuca A, Wurzer P, Spendel SM, Forbes AA, Spendel S, Schintler M, Haxhija E, Schwenzer-Zimmerer K, Friedl H, et al. Complications in tissue expansion: a logistic regression analysis for risk factors. Burns. 2017;43:1195–1202. doi: 10.1016/j.burns.2016.08.030. PubMed DOI
Masheb RM, Lutes LD, Kim HM, Holleman RG, Goodrich DE, Janney CA, Kirsh S, Higgins DM, Richardson CR, Damschroder LJ. Weight loss outcomes in patients with pain. Obesity. 2015;23:1778–1784. doi: 10.1002/oby.21160. PubMed DOI
Yang H-Y, Chen H-J, Hsu Y-J, Cheskin LJ, Wang Y. Impact of weight-related advice from healthcare professionals on body mass index of patients in the USA. Public Health. 2018;159:50–57. doi: 10.1016/j.puhe.2018.02.027. PubMed DOI PMC
Cheikh Rouhou M, Karelis AD, St-Pierre DH, Lamontagne L. Adverse effects of weight loss: are persistent organic pollutants a potential culprit? Diabetes Metab. 2016;42:215–223. doi: 10.1016/j.diabet.2016.05.009. PubMed DOI
Køster-Rasmussen R. Weight changes in general practice. Dan Med J. 2017;64:B5376. PubMed
Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, Krapfenbauer K, Mozaffari MS, Costigliola V. Medicine in the early twenty-first century: paradigm and anticipation - EPMA Position Paper 2016. EPMA J 2016; 7. 10.1186/s13167-016-0072-4. PubMed PMC
Koliaki C, Spinos T, Spinou Μ, Brinia Μ-E, Mitsopoulou D, Katsilambros N. Defining the optimal dietary approach for safe, effective and sustainable weight loss in overweight and obese adults. Healthcare (Basel) 2018;6:73. doi: 10.3390/healthcare6030073. PubMed DOI PMC
Golubnitschaja O, Costigliola V. EPMA General report & recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive Preventive and Personalised Medicine. EPMA J. 2012;3:14. doi: 10.1186/1878-5085-3-14. PubMed DOI PMC
Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V. Position Paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J. 2013;4:12. doi: 10.1186/1878-5085-4-12. PubMed DOI PMC
Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, Preventive and Personalised Medicine as the hardcore of ‘horizon 2020’: EPMA Position Paper. EPMA J. 2014;5:6. doi: 10.1186/1878-5085-5-6. PubMed DOI PMC
Golubnitschaja O, Costigliola V. EPMA EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements. EPMA J. 2015;6:4. doi: 10.1186/s13167-015-0026-2. PubMed DOI PMC
Birkenbihl C, Emon MA, Vrooman H, Westwood S, Lovestone S, Hofmann-Apitius M, Fröhlich H. On behalf of the AddNeuroMed consortium; Alzheimer’s disease neuroimaging initiative differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice. EPMA J. 2020;11:367–376. doi: 10.1007/s13167-020-00216-z. PubMed DOI PMC
Emon MA, Heinson A, Wu P, Domingo-Fernández D, Sood M, Vrooman H, Corvol J-C, Scordis P, Hofmann-Apitius M, Fröhlich H. Clustering of Alzheimer’s and Parkinson’s disease based on genetic burden of shared molecular mechanisms. Sci Rep. 2020;10:19097. doi: 10.1038/s41598-020-76200-4. PubMed DOI PMC
Karabatsiakis A, Hamuni G, Wilker S, Kolassa S, Renu D, Kadereit S, Schauer M, Hennessy T, Kolassa IT. Metabolite profiling in posttraumatic stress disorder. J Mol Psychiatry. 2015;3(1):2. doi: 10.1186/s40303-015-0007-3. PubMed DOI PMC
Karabatsiakis A, König AM, Stoll T, Wilker S, Hennessy T, Hill MM, Kolassa IT. Serum profile changes in postpartum women with a history of childhood maltreatment: a combined metabolite and lipid fingerprinting study. Sci Rep. 2018;8:3468. doi: 10.1038/s41598-018-21763-6. PubMed DOI PMC
Birkenbihl C, Salimi Y, Fröhlich H. Unraveling the heterogeneity in Alzheimer’s disease progression across multiple cohorts and the implications for data-driven disease modeling. Alzheimer’s & Dementia n/a. 10.1002/alz.12387. PubMed
Barrett M, Boyne J, Brandts J, Brunner-La Rocca H-P, De Maesschalck L, De Wit K, Dixon L, Eurlings C, Fitzsimons D, Golubnitschaja O, et al. Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to Predictive Preventive and Personalised Care. EPMA J. 2019;10:445–464. doi: 10.1007/s13167-019-00188-9. PubMed DOI PMC
Goldstein E, Yeghiazaryan K, Giordano FA, Ahmad A, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3PM recommendations. EPMA J. 2020;11:505–515. doi: 10.1007/s13167-020-00221-2. PubMed DOI PMC
Golriz Khatami S, Robinson C, Birkenbihl C, Domingo-Fernández D, Hoyt CT, Hofmann-Apitius M. Challenges of integrative disease modeling in Alzheimer’s disease. Front Mol Biosci. 2020;0. 10.3389/fmolb.2019.00158. PubMed PMC
Birkenbihl C, Salimi Y, Domingo-Fernándéz D, Lovestone S, Fröhlich H, Hofmann-Apitius M. Evaluating the Alzheimer’s disease data landscape. Alzheimers Dement. 2020;6:e12102. doi: 10.1002/trc2.12102. PubMed DOI PMC
Fröhlich H, Balling R, Beerenwinkel N, Kohlbacher O, Kumar S, Lengauer T, Maathuis MH, Moreau Y, Murphy SA, Przytycka TM, et al. From hype to reality: data science enabling personalized medicine. BMC Med. 2018;16:150. doi: 10.1186/s12916-018-1122-7. PubMed DOI PMC
Javed A, Tebben PJ, Fischer PR, Lteif AN. Female athlete triad and its components: toward improved screening and management. Mayo Clin Proc. 2013;88(9):996–1009. doi: 10.1016/j.mayocp.2013.07.001. PubMed DOI
Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care